Arvinas to Present at the Guggenheim Healthcare Talks: 2021 Oncology Day

NEXT STORY
Burning Rock Announces Preliminary Fourth Quarter and Full Year 2020 Results and Schedules Earnings Release on March 11, 2021
PREV STORY
Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Precipio Announces Third Quarter 2018 Revenues Estimated to be 2.4 Times Third Quarter of 2017 Revenues

Fourth consecutive Quarter of Triple-Digit Year-over-Year Quarterly Revenue Growth; Year-to-Date Revenues Increased 163% over ...

author_avatar
NASDAQ Market News

Midatech Pharma Plc: Trading Update and Notice of Results

OXFORDSHIRE, United Kingdom, Aug. 10, 2016 (GLOBE NEWSWIRE) --   Midatech Pharma PLC ("Midatech" ...

author_avatar
NASDAQ Market News

TESARO Announces Niraparib Data Presentations at the 2017 SGO Annual Meeting on Women’s Cancer

WALTHAM, Mass., March 12, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical ...

author_avatar
NASDAQ Market News